CBS Boston reports on a clinical trial that leverages kidneys infected with hepatitis C, potentially making many new organs available. “We’re giving [patients] the opportunity to have a transplant but we’re also treating them for a new infection they didn’t have. So that’s the trade-off,” commented Peter Reese, MD, MSCE.
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. LEARN MORE ABOUT US